1 – 10 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Animal models for preclinical Parkinson´s research: An update and critical appraisal
Cenci Nilsson, Angela LU
and
Björklund, Anders
LU
(2020)
In Progress in Brain Research
252.
p.27-59
Mark
- D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease
- Preface : The evolving scenario of Parkinson's research
-
The role of glia in Parkinson's disease : Emerging concepts and therapeutic applications
Kuter, Katarzyna Z. LU ; Cenci, M. Angela LU
and
Carta, Anna R.
(2020)
In Progress in Brain Research
252.
p.131-168
Mark
- 2019
-
Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy
Espa, Elena LU ; Clemensson, Erik K.H. LU ; Luk, Kelvin C. ; Heuer, Andreas LU ; Björklund, Tomas LU and Cenci, M. Angela LU
(2019)
In Movement Disorders
34(11).
p.1699-1710
Mark
-
Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease
Petersson, Per LU ; Halje, Pär LU and Cenci, M. Angela LU
(2019)
In Journal of Parkinson's Disease
9(1).
p.183-196
Mark
-
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
Francardo, Veronica LU ; Geva, Michal ; Bez, Francesco LU ; Denis, Quentin LU ; Steiner, Lilach ; Hayden, Michael R. and Cenci, M. Angela LU
(2019)
In Neurotherapeutics
16(2).
p.465-479
Mark
-
Dyskinesia matters
Cenci, M. Angela LU
;
Riggare, Sara
;
Pahwa, Rajesh
;
Eidelberg, David
and
Hauser, Robert A.
(2019)
In Movement Disorders
Mark
- 2018
-
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
Cenci, M. Angela LU
;
Jörntell, Henrik
LU
and
Petersson, Per
LU
(2018)
In Journal of Neural Transmission
125(8).
p.1157-1169
Mark
-
mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
Sebastianutto, Irene LU and Cenci, Maria Angela LU
(2018)
In Current Opinion in Pharmacology
38.
p.81-89
Mark